Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Current evidence and new trends in anal fissure treatment.

Domínguez-Muñoz M., Balla A., Gómez-Rosado JC., Morales-Conde S.

Narrative Review on Chronic Wound, published in Minerva Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Minerva Surg (2025)
Country
Italy
Reported sample size
—
Source database
PubMed
PMID
40401587
DOI
10.23736/S2724-5691.25.10778-8

Abstract (original English)

An anal fissure is a benign and painful ulcer extending from the pectinate line to the anal margin. It leads to an increase in the resting pressure of the internal anal sphincter and the pressure within the anal canal, resulting in local ischemia and impaired wound healing. Anal fissures are mostly located in the posterior midline. They are primarily caused by local trauma to the anoderm, often due to the passage of hard stools, irritation from diarrhea, or anorectal surgery. For both acute and chronic anal fissures, several treatment options are available, and surgery typically reserved as a second-line option. Recent trends in first-line therapy prefer calcium channel blockers (CCBs) over topical glyceryl trinitrate (GTN), as they offer similar healing rates but are associated with fewer side effects and better patient's compliance. Lateral internal sphincterotomy (LIS) remains the gold-standard surgical treatment for this condition. Additionally, emerging therapies, such as platelet-rich plasma (PRP) application, adipose-derived regenerative cells (ADRCs), and percutaneous tibial nerve stimulation (PTNS), have shown promising results and they are gaining attention as potential alternatives for managing chronic anal fissures. The present narrative review aims to provide a comprehensive overview of current therapeutic approaches for anal fissures, evaluating their effectivenes

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansFissure in AnoNitroglycerinSphincterotomyPlatelet-Rich PlasmaCalcium Channel BlockersChronic DiseaseWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research